Delivery Order SPE2DB22D1017-SPE2DB24FF5KN
Award Date 4/5/24
Potential Completion Date 4/8/24
Potential Value $15K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,036.41 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide NAFTIFINE HCL 1% CREAM 60GM. The contract has a completion date of January 29, 2024. Amerisourcebergen Drug Corp is the prime contractor and has an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Naftifine HCL 2% Gel in 60-gram units, with a ceiling value of $2,343.43. This is a firm fixed-price delivery order with no set-aside designation, issued competitively to the prime contractor. The contract is scheduled for completion by November 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a for-profit organization and subsidiary of Amerisourcebergen Corporation. The $24,326.12 firm fixed price delivery order is for the supply of NAFTIFINE HCL 2% GEL 45GM, a pharmaceutical product. The award has an ultimate completion date of April 1, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 31,...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,417.26 Firm Fixed Price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division. The order is for the supply of 4565519719 - NAFTIFINE HCL 1% CREAM 60GM, with an ultimate completion date of August 21, 2024. This contract award is part of Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for delivering a comprehensive range of...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,057.46 firm-fixed-price contract is for the delivery of Naftifine HCL 2% gel, a topical antifungal medication, with a completion date of April 25, 2024. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,210.56 firm fixed-price delivery order contract is for the supply of NAFTIFINE HCL 2% CREAM 60GM, a pharmaceutical product. The contract is not designated as a set-aside and has an ultimate completion date of April 2, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,383.03, is for the delivery of 4564880821 - Naftifine HCL 2% Gel 60GM. This is a firm fixed-price contract without any set-aside designation, indicating open competition. Amerisourcebergen also holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Naftifine HCL 2% Gel in 60-gram quantities, with a ceiling value of $1,073.57. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Naftifine HCL 2% cream in 60-gram quantities. The $1,057.51 firm fixed-price delivery order contract has a completion date of May 28, 2025. The contract is not set-aside and is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This IDC provides a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,125.43 Firm Fixed Price delivery order contract is for the supply of Naftifine HCL 2% Gel, a pharmaceutical product. The contract has an ultimate completion date of December 30, 2024 and was awarded on December 27, 2024. No set-aside designation was used for this award. Amerisourcebergen holds a $999,999,999...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FF5KNDelivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide NAFTIFINE HCL 2% GEL 60GM. The contract has a ceiling value of $15,068.59 and a period of performance through April 8, 2024. This delivery order is part of an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract does not have a set-aside designation.
Generated 7/5/24, 9:08 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.1k | 4/5/24 |